Skip to main content
SpringerLink
Log in
SpringerLink
Log in

COPD: Ursachen — Zusammenhänge — Prävention

  • Chapter
Volkskrankheit Asthma/COPD

Zusammenfassung

In Deutschland rauchen über 30% der Bevölkerung regelmäßig. Während bei Männern in den letzten Jahren das Rauchverhalten langsam rückläufig war, ist bei den Frauen noch eine Zunahme des Tabakrauchens zu verzeichnen (Tabelle 1). Bei Jugendlichen istes über Jahrzehnte zu einer Abnahme des Eintrittsalters in den Tabakkonsum gekommen. Nach einer Untersuchung der Bundeszentrale für gesundheitliche Aufk lärung (BZgA) zufolge rauchen im Jahr 2005 21% aller männlichen und 19% aller weiblichen Jugendlichen (Alter: 12–17 Jahre) [1]. Das Durchschnittsalter, in dem zum ersten Mal regelmäßig geraucht wurde, wird zwischen dem 13. und 14. Lebensjahr angegeben. Laut aktueller Daten der WHO und der Europäischen Union liegt Deutschland bezüglich des Tabakkonsums im oberen Drittelund bei Tabak-Kontrollmaßnahmen im unterem Viertel der Staaten der EU [2].

Gesamtanteil der Raucher in der 25- bis 69-jährigen Bevölkerung (Mikrozensus-Umfrage 2003; 1984–1986 nur alte Bundesländer) [1]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. DESTATIS (2005). Rauchverhalten nach Altersgruppen Ergebnisse der Mikrozensus-Befragung.

    Google Scholar 

  2. Consortium, A. (2004). Tobacco or health in the european union, European Commission: 1–295.

    Google Scholar 

  3. Doll, R., R. Peto, et al. (2004). “Mortality in relation to smoking: 50 years’ observations on male British doctors.” Bmj 328(7455): 1519.

    Article  PubMed  Google Scholar 

  4. Konietzko, N. and H. Fabel (2000). Weißbuch Lunge 2000. Stuttgart, Georg Thieme Verlag.

    Google Scholar 

  5. Welte, R., H. H. König, et al. (2000). “Cost of health damage and productivity losses attributable to cigarette smoking in Germany.” Eur J Publ Health 10(1): 31–38.

    Article  Google Scholar 

  6. John, U. and M. Hanke (2001). “[Tobacco smoking attributable mortality in Germany].” Gesundheitswesen 63(6): 363–9.

    Article  CAS  PubMed  Google Scholar 

  7. Batra, A. (2004). Tabakbedingte Störungen „Leitlinie Tabakentwöhnung“, AWMF online, Leitlinien der Dt. Ges. f. Suchtforschung und Suchttherapie (DG-Sucht) und der Dt. Ges. f. Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN).

    Google Scholar 

  8. Fidler, J. A., J. Wardle, et al. (2006). “Vulnerability to smoking after trying a single cigarette can lie dormant for three years or more.” Tob Control 15(3): 205–9.

    Article  CAS  PubMed  Google Scholar 

  9. Vink, J. M., G. Willemsen, et al. (2005). “Heritability of smoking initiation and nicotine dependence.” Behav Genet 35(4): 397–406.

    Article  PubMed  Google Scholar 

  10. Godtfredsen, N. S., J. Vestbo, et al. (2002). “Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study.” Thorax 57(11): 967–72.

    Article  CAS  PubMed  Google Scholar 

  11. Meyer, P. A., D. M. Mannino, et al. (2002). “Characteristics of adults dying with COPD.” Chest 122(6): 2003–8.

    Article  PubMed  Google Scholar 

  12. Calverley, P., R. Pauwels, et al. (2003). “Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.” Lancet 361(9356): 449–56.

    Article  CAS  PubMed  Google Scholar 

  13. Szafranski, W., A. Cukier, et al. (2003). “Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.” Eur Respir J 21(1): 74–81.

    Article  CAS  PubMed  Google Scholar 

  14. Criee, C. P. and D. Novak (2006). Einsparpotential durch Prävention bei COPD. Zukunft sichern: Senkung der Zahl chronisch Kranker, Verwirklichung einer realistischen Utopie. P. Schauder, H. Berthold, H. Eckel and G. Ollenschläger. Köln, Deutscher Ärtzeverlag: 205–208.

    Google Scholar 

  15. Jimenez-Ruiz, C., M. Miravitlles, et al. (2004). “Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?” Nicotine Tob Res 6(4): 649–53.

    Article  CAS  PubMed  Google Scholar 

  16. van der Meer, R. M., E. J. Wagena, et al. (2004). Smoking cessation for chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library. Chichester, UK, John Wiley & Sons, Ltd. 3.

    Google Scholar 

  17. Wilhelm, K., K. Arnold, et al. (2004). “Grey lungs and blue moods: smoking cessation in the context of lifetime depression history.” Aust N Z J Psychiatry 38(11–12): 896–905.

    PubMed  Google Scholar 

  18. Murray, C. J. and A. D. Lopez (1997). “Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.” Lancet 349(9064): 1498–504.

    Article  CAS  PubMed  Google Scholar 

  19. Burney, P., S. Suissa, et al. (2003). “The pharmacoepidemiology of COPD: recent advances and methodological discussion.” Eur Respir J Suppl 43: 1s–44s.

    Google Scholar 

  20. Wedzicha, J. A. and G. C. Donaldson (2003). “Exacerbations of chronic obstructive pulmonary disease.” Respir Care 48(12): 1204–13; discussion 1213–5.

    PubMed  Google Scholar 

  21. Lundback, B., A. Lindberg, et al. (2003). “Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.” Respir Med 97(2): 115–22.

    Article  CAS  PubMed  Google Scholar 

  22. de Marco, R., S. Accordini, et al. (2004). “An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.” Thorax 59(2): 120–5.

    Article  PubMed  Google Scholar 

  23. Cookson, W. O. (2006). “State of the art. Genetics and genomics of chronic obstructive pulmonary disease.” Proc Am Thorac Soc 3(6): 473–5.

    Article  CAS  PubMed  Google Scholar 

  24. Wouters, E. F. (2002). “Chronic obstructive pulmonary disease. 5: systemic effects of COPD.” Thorax 57(12): 1067–70.

    Article  CAS  PubMed  Google Scholar 

  25. Reid, M. B. (2001). “COPD as a muscle disease.” Am J Respir Crit Care Med 164(7): 1101–2.

    CAS  PubMed  Google Scholar 

  26. Andreas, S., S. D. Anker, et al. (2005). “Neurohumoral activation as a link to systemic manifestation of chronic lung disease.” Chest 128: 3618–3624.

    Article  PubMed  Google Scholar 

  27. Anthonisen, N. R., J. E. Connett, et al. (2002). “Hospitalizations and mortality in the Lung Health Study.” Am J Respir Crit Care Med 166(3): 333–9.

    Article  PubMed  Google Scholar 

  28. Cerveri, I., S. Accordini, et al. (2003). “Chronic cough and phlegm in young adults.” Eur Respir J 22(3): 413–7.

    Article  CAS  PubMed  Google Scholar 

  29. Vestbo, J., E. Prescott, et al. (1996). “Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.” Am J Respir Crit Care Med 153(5): 1530–5.

    CAS  PubMed  Google Scholar 

  30. Kerstjens, H. A., B. Rijcken, et al. (1997). “Decline of FEV1 by age and smoking status: facts, figures, and fallacies.” Thorax 52(9): 820–7.

    Article  CAS  PubMed  Google Scholar 

  31. Gold, D. R., X. Wang, et al. (1996). “Effects of cigarette smoking on lung function in adolescent boys and girls.” N Engl J Med 335(13): 931–7.

    Article  CAS  PubMed  Google Scholar 

  32. Sherrill, D. L., M. D. Lebowitz, et al. (1991). “Smoking and symptom effects on the curves of lung function growth and decline.” Am Rev Respir Dis 144(1): 17–22.

    CAS  PubMed  Google Scholar 

  33. Fletcher, C. and R. Peto (1977). “The natural history of chronic airflow obstruction.” Br Med J 1(6077): 1645–8.

    Article  CAS  PubMed  Google Scholar 

  34. Scanlon, P. D., J. E. Connett, et al. (2000). “Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.” Am J Respir Crit Care Med 161(2 Pt 1): 381–90.

    CAS  PubMed  Google Scholar 

  35. Viegi, G., D. L. Sherrill, et al. (2001). “An 8-year follow-up of carbon monoxide diff using capacity in a general population sample of northern italy.” Chest 120(1): 74–80.

    Article  CAS  PubMed  Google Scholar 

  36. Verbanck, S., D. Schuermans, et al. (2006). “Small airway function improvement after smoking cessation in smokers without airway obstruction.” Am J Respir Crit Care Med 174(8): 853–7.

    Article  PubMed  Google Scholar 

  37. Janson, C., N. Künzli, et al. (2006). “Change in active and passive smoking in the EU respiratory health survey.” Eur Respir J 27: 517–524.

    Article  CAS  PubMed  Google Scholar 

  38. Raupach, T., K. Schafer, et al. (2006). “Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm.” Eur Heart J 27(4): 386–92.

    Article  PubMed  Google Scholar 

  39. Society, E. R. (2006). Lifting the smoke screen −10 reasons for a smoke free Europe. B-1000, Brussels, European Respiratory Society: 28 ff.

    Google Scholar 

  40. Jaakkola, M. S. and J. J. Jaakkola (2006). “Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention.” Eur Respir J 28(2): 397–408.

    Article  CAS  PubMed  Google Scholar 

  41. Tashkin, D., R. Kanner, et al. (2001). “Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.” Lancet 357(9268): 1571–5.

    Article  CAS  PubMed  Google Scholar 

  42. Wagena, E. J., M. J. Huibers, et al. (2001). “kAntidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.” Thorax 56(8): 587–8.

    Article  CAS  PubMed  Google Scholar 

  43. Wagena, E. J., M. P. Zeegers, et al. (2003). “Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.” Drug Saf 26(6): 381–403.

    Article  CAS  PubMed  Google Scholar 

  44. Bednarek, M., D. Gorecka, et al. (2006). “Smokers with airway obstruction are more likely to quit smoking.” Thorax.

    Google Scholar 

  45. Simmons, M. S., J. E. Connett, et al. (2005). “Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study.” Eur Respir J 25(6): 1011–7.

    Article  CAS  PubMed  Google Scholar 

  46. Pauwels, R. A., A. S. Buist, et al. (2001). “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.” Am J Respir Crit Care Med 163(5): 1256–76.

    CAS  PubMed  Google Scholar 

  47. Lacasse, Y., J. LaForge, et al. (2006). “Got a match? Home oxygen therapy in current smokers.” Thorax 61(5): 374–5.

    Article  CAS  PubMed  Google Scholar 

  48. Ruff, L. K., T. Volmer, et al. (2000). “The economic impact of smoking in Germany.” Eur Respir J 16(3): 385–90.

    Article  CAS  PubMed  Google Scholar 

  49. Parrott, S., C. Godfrey, et al. (2000). “Costs ofemployee smoking in the workplace in Scotland.” Tob Control 9(2): 187–92.

    Article  CAS  PubMed  Google Scholar 

  50. Felten, D., T. Raupach, et al. (2006). „Effektivitäteines klinikbasierten kognitiv-verhaltenstherapeutischen Raucherentwöhnungsprogramms mit pharmakologischer Unterstützung.“ Deut Med Wochschr 131: 197–202.

    Article  CAS  Google Scholar 

  51. Murray, R. P., J. E. Connett, et al. (2002). “Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years.” Prev Med 35(4): 314–9.

    Article  PubMed  Google Scholar 

  52. McBride, C. M., S. J. Curry, et al. (1998). “Partner smoking status and pregnant smoker’s perceptions of support for and likelihood of smoking cessation.” Health Psychol 17(1): 63–9.

    Article  CAS  PubMed  Google Scholar 

  53. Raw, M., A. McNeill, et al. (1998). “Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Healtheducation Authority.” Thorax 53 Suppl 5: S1–19.

    Article  Google Scholar 

  54. The Health Consequences of Smoking: A Report of the Surgeon General (2004). Atlanta, GA:, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.

    Google Scholar 

  55. Fiore, M. C. (2000). “Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline.” Respir Care 45(10): 1196–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lungenfachklinik, Robert-Koch-Straße 3, 34376, Immenhausen

    Prof. Dr. Stefan Andreas (Leitender Arzt)

Authors
  1. Prof. Dr. Stefan Andreas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover

    Heidrun Lingner  & Friedrich-Wilhelm Schwartz  & 

  2. Fachklinik Allgäu, Peter-Heel-Straße 29, 87459, Pfronten-Ried

    Konrad Schultz

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Andreas, S. (2007). COPD: Ursachen — Zusammenhänge — Prävention. In: Lingner, H., Schwartz, FW., Schultz, K. (eds) Volkskrankheit Asthma/COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70920-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-70920-6_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-70919-0

  • Online ISBN: 978-3-540-70920-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation